MedPath

Clinical study of an Ayurveda formulation containing Gold and Indian Gooseberry along with Tulasi juice as an add on therapy in standard care of COVID 19 patients

Phase 2
Completed
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2020/10/028414
Lead Sponsor
Ministry of AYUSH New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
65
Inclusion Criteria

1.Diagnosed patients of COVID 19with positive RT-PCR test of either sex, between the age group of 20 -70 years

2.Patients of COVID 19 receiving standard treatment protocol as prescribed by ICMR/MOHFW, Govt. of India

3.Patients giving informed consent

Exclusion Criteria

1.COVID 19 patients requiring ventilator support

2.Pregnant ladies and children

3.COVID 19 patients with other severe, unstable, uncontrolled co-morbid medical illness such as Diabetes, Hypertension, Cardiac disorders, liver, kidney disorders and lung disorders or other diseases of concern which may put the patient in risk during the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath